Fractyl Health, Inc. Common Stock GUTS
GUTS
Fractyl Health, Inc. Common Stock ADVM
Adverum Biotechnologies, Inc. ALXO
ALX Oncology Holdings Inc. DTIL
Precision BioSciences, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. QNCX
Quince Therapeutics, Inc. MGX
Metagenomi, Inc. Common Stock RPTX
Repare Therapeutics Inc. ATYR
aTyr Pharma, Inc.
Fractyl Health, Inc. Common Stock ADVM
Adverum Biotechnologies, Inc. ALXO
ALX Oncology Holdings Inc. DTIL
Precision BioSciences, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. QNCX
Quince Therapeutics, Inc. MGX
Metagenomi, Inc. Common Stock RPTX
Repare Therapeutics Inc. ATYR
aTyr Pharma, Inc.
Performance
| Periode | GUTS | ADVM | ALXO | DTIL | ARTV | STRO | QNCX | MGX | RPTX | ATYR |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 8.98 % | 77.24 % | 188.84 % | 2.24 % | 66.67 % | 22.53 % | 194.41 % | 15.73 % | 45.58 % | -85.19 % |
| YTD | 5.40 % | -9.17 % | -5.13 % | 6.82 % | -66.90 % | -49.27 % | 123.94 % | -56.33 % | 62.12 % | -80.30 % |
| 1Y | 10.05 % | -17.11 % | -3.90 % | -7.90 % | -68.93 % | -53.82 % | 107.39 % | -48.92 % | 20.90 % | -74.83 % |
| 3Y | -82.53 % | -30.90 % | -86.81 % | -86.08 % | -72.50 % | -87.14 % | 503.15 % | -83.95 % | -86.15 % | -55.48 % |
| 5Y | -82.53 % | -96.89 % | -98.15 % | -97.92 % | -72.50 % | -95.49 % | -86.01 % | -83.95 % | -94.58 % | -55.48 % |
| 10Y | -82.53 % | -94.78 % | -95.07 % | -99.04 % | -72.50 % | -93.56 % | -87.20 % | -83.95 % | -93.05 % | -55.48 % |
| Depuis le début | -82.53 % | -98.44 % | -95.07 % | -99.04 % | -72.50 % | -93.56 % | -87.20 % | -83.95 % | -93.05 % | -55.48 % |